Curaleaf T20:C1 – Royal Moby

Report Abuse

curaleaf curaleaf
Most Viewed
0 0 Reviews
£65.00

 

Curaleaf T20:C1 - Royal Moby is a Sativa dominant strain of cannabis characterised by 20%  THC and <1% CBD (content by weight).

Curaleaf T20:C1 - Royal Moby is cultivated in Australia by ECS Botanics.

0%
THC
0%
CBD

Cultivar Manufacturing Terpenes
Strain:Royal Moby Origin:
Australia
    
Lineage: Haze X White Widow Manufacturer:ECS Botanics Description of Taste: Spicey, Lemon, Earthy, Citrus
Genetics: 65% Sativa / 35% Indica Grow Type: Greenhouse (Hybrid) Description of Smell: Blueberry, Citrus, Earthy, Herbal

Commonly Prescribed For:  Anxiety, Back Pain, Depression, Abdominal Pain

Patient FeedbackBalanced, Clear, Relaxed, Comfortable, Hungry, Uplifted

Effect:

7 -

Tags

Information

Specification

Type
Sativa
Cultivar
Royal Moby
THC
20%
CBD
<1%
Terpene 1
Terpinolene
Terpene 2
Myrcene
Terpene 3
Caryophyllene
Origin
Australia
Brand
Curaleaf
Post Harvesting - Bioburden Reduction Method
Gamma Irradiation - Cobalt 60
 

Supporting Documents

Supporting Documents

Patient Information Leaflet

Availability, Pricing & Discount Schemes

Price

Sizes / Weights
10g
Current Availability
In Stock
Cost
10g from £65

Access Schemes

Available On Project Twenty21
Unknown

Reviews

Curaleaf T20:C1 – Royal Moby 0 reviews

Write Your Review

There are no reviews yet.

Write Your Review

Your email address will not be published. Required fields are marked *

Gallery & Videos

Images provided by patients. Looking to submit your own? Use our simple forms to upload your own images. 

Prescribing Clinics

Prescribing Clinics

Dispensing Pharmacies

Dispensing Pharmacies